Although there are many studies of leadership in military teams, few have focused on military team factors that could be linked to shared leadership in an international military staff. The focus of shared leadership is on team members' interacting in order to lead collectively by sharing leadership tasks, rather than on an individual being a sole leader. The aim of this study is to identify predictors of a positive attitude toward shared leadership in the context of military teams, and how they are related to perceived team effectiveness. Results show that task complexity is the critical predictor of a positive attitude toward shared leadership, and that attitude toward shared leadership is positively related to perceived team effectiveness through self-management in a military context. What is more, when self-management is low in military teams, trust compensates to increase the perceived effectiveness. The findings contribute to the literature on attitude toward shared leadership in the specific context of international military teams.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013440 | PMC |
| http://dx.doi.org/10.1080/08995605.2021.1962179 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reaccreditation and Pathways Recognition Experiences of Small Local and Tribal Health Departments.
J Public Health Manag Pract
November 2024
Author Affiliations: Prevention Research Center, Brown School, Washington University in St. Louis, St. Louis, Missouri (Allen and Crenshaw); Department of Health Policy and Organization, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama (Fifolt); School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama (Erwin); Research and Evaluation, Public Health Accreditation Board, Alexandria, Virginia (Lang, Belflower Thomas, and Kuehnert); and Lipstein Distinguished Professor of Public Health, Prevention Research Center, Brown School, and Alvin J. Siteman Cancer Center and Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine; Washington University in St. Louis, St. Louis, Missouri (Brownson).
Context: This paper describes experiences and views of leadership teams from 4 small local health departments (LHDs) seeking Public Health Accreditation Board (PHAB) reaccreditation or Pathways Recognition using PHAB Standards & Measures Version 2022. The Pathways program launched in 2022 provides additional supports for improvement of public health practice.
Objective: Given the need to accelerate accreditation among small health departments, the purpose of this study is to share small health departments' strategies for overcoming accreditation challenges and actionable advice for use by other health departments.
Prioritization and multilevel mapping of implementation strategies for a cancer rehabilitation navigation program.
PM R
January 2025
Center for Outcomes Analytics and Research, Brooks Rehabilitation Hospital, Jacksonville, FL, USA.
Background: Although determinants and strategies for implementing a cancer rehabilitation navigation (CRNav) program have been described, defining specific implementation interventions could improve uptake in oncology care delivery. This manuscript shares prioritized implementation interventions using a multilevel framework.
Methods: We convened interdisciplinary stakeholders from two CRNav programs to participate in an implementation mapping focus group.
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
J Prev Alzheimers Dis
January 2025
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA. Electronic address:
Background: There are no approved oral disease-modifying treatments for Alzheimer's disease (AD).
Objectives: The objective of this study was to assess efficacy and safety of blarcamesine (ANAVEX®2-73), an orally available small-molecule activator of the sigma-1 receptor (SIGMAR1) in early AD through restoration of cellular homeostasis including autophagy enhancement.
Design: ANAVEX2-73-AD-004 was a randomized, double-blind, placebo-controlled, 48-week Phase IIb/III trial.
Leading by example: Experimental evidence that therapist lived experience disclosures can model the path to recovery for clients.
Br J Psychol
January 2025
School of Medicine and Psychology, The Australian National University, Canberra, Australian Capital Territory, Australia.
A common guideline for self-disclosure is that therapists should only share recovered personal experiences with clients (i.e., no longer distressing).
View Article and Find Full Text PDFOpicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial.
Eur J Neurol
January 2025
Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Background: Catechol-O-methyl transferase (COMT) inhibitors are routinely used to manage motor fluctuations in Parkinson's disease (PD). We assessed the effect of opicapone on motor symptom severity in levodopa-treated patients without motor complications.
Methods: This was a randomized, double-blind, 24-week, placebo-controlled study of opicapone 50 mg as adjunct to levodopa (NCT04978597).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!